imiquimod has been researched along with Delayed Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akimoto, T; Ishizaki, M; Maeda, H; Matsuda, T; Muromoto, R; Ohshiro, Y; Oritani, K; Sekine, Y; Shimoda, K; Yokoyama, M | 1 |
| Cheung, PH; Foreman, O; Hain, HS; Kaur, P; Kavirayani, A; Saha, S; Tung, D | 1 |
2 other study(ies) available for imiquimod and Delayed Hypersensitivity
| Article | Year |
|---|---|
Involvement of tyrosine kinase-2 in both the IL-12/Th1 and IL-23/Th17 axes in vivo.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Differentiation; Colitis; Dextran Sulfate; Drug Delivery Systems; Hypersensitivity, Delayed; Imiquimod; Interleukin-12; Interleukin-23; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Psoriasis; Th1 Cells; Th17 Cells; Trinitrobenzenesulfonic Acid; TYK2 Kinase | 2011 |
Anti-inflammatory and immunomodulatory effects of bortezomib in various in vivo models.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Anti-Inflammatory Agents; Boronic Acids; Bortezomib; Dinitrofluorobenzene; Disease Models, Animal; Drug Compounding; Drug Evaluation, Preclinical; Drug Stability; Female; Hypersensitivity, Delayed; Imiquimod; Immunologic Factors; Irritants; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Peritonitis; Psoriasis; Pyrazines; Random Allocation; Temperature; Thioglycolates | 2011 |